Mach-1 Financial Group’s Edwards Lifesciences EW Stock Holding History

Mach-1 Financial Group’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,507	Closed	-$431K	–	306
2025 Q2	$431K	Buy	+5,507	New	+$411K	0.13%	132
2023 Q3	–	Sell	-11,615	Closed	-$1.1M	–	213
2023 Q2	$1.1M	Buy	+11,615	New	+$1.01M	0.31%	54

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Mach-1 Financial Group's EW Position: Q3 2025 in Review

Mach-1 Financial Group sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 5,507 shares — an estimated $431K sold.

Mach-1 Financial Group first reported a position in EW in Q2 2023 and held it in 2 quarters. The position peaked at $1.1M in Q2 2023. 1,254 funds tracked by Wall St. Rank hold EW as of Q3 2025.

Mach-1 Financial Group reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
Mach-1 Financial Group sold 5,507 Edwards Lifesciences shares in Q3 2025, an estimated $431K.
Mach-1 Financial Group first reported a position in Edwards Lifesciences in Q2 2023 and held it in 2 quarters.
Mach-1 Financial Group's Edwards Lifesciences position peaked at $1.1M in Q2 2023.
1,254 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Mach-1 Financial Group's 13F filing for Q3 2025, filed 12 Nov 2025.